Chasing a Moving Target: End-to-End Testing with QUASAR HD Motion Platform & pRESP2.0
Target motion remains one of the biggest uncertainties in radiotherapy. This webinar explores how the HD Motion Platform and pRESP 2.0 can transform traditional static end to end testing into a dynamic system test, allowing the entire treatment chain to be evaluated under realistic motion conditions.
Clinical Application Specialist at IBA Dosimetry